Liqiang Pan

1.2k total citations · 1 hit paper
35 papers, 816 citations indexed

About

Liqiang Pan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Liqiang Pan has authored 35 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Oncology. Recurrent topics in Liqiang Pan's work include Monoclonal and Polyclonal Antibodies Research (20 papers), CAR-T cell therapy research (10 papers) and HER2/EGFR in Cancer Research (8 papers). Liqiang Pan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (20 papers), CAR-T cell therapy research (10 papers) and HER2/EGFR in Cancer Research (8 papers). Liqiang Pan collaborates with scholars based in China, United States and South Korea. Liqiang Pan's co-authors include Shuqing Chen, Yingchun Xu, Shijie Jin, Yanping Sun, Liang Xiao, Xinyu Gu, James J. Chou, Wenbin Zhao, Xin Liu and Ming Ye and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Liqiang Pan

32 papers receiving 804 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging new therapeutic antibody derivatives for cancer treatment

2022 294 citations Shijie Jin, Yanping Sun et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liqiang Pan China	14	450	292	286	216	97	35	816
Hyunbo Shim South Korea	17	439 1.0×	174 0.6×	310 1.1×	173 0.8×	40 0.4×	42	762
Stephanie C. Pero United States	18	633 1.4×	284 1.0×	373 1.3×	131 0.6×	41 0.4×	38	926
Shauna West United Kingdom	15	526 1.2×	102 0.3×	289 1.0×	168 0.8×	47 0.5×	20	849
Sri Murugan Poongkavithai Vadevoo South Korea	14	518 1.2×	161 0.6×	61 0.2×	347 1.6×	179 1.8×	15	877
Natália Rodrigues Mantuano Switzerland	11	588 1.3×	187 0.6×	88 0.3×	349 1.6×	35 0.4×	17	795
Halina Onishko United States	8	363 0.8×	139 0.5×	65 0.2×	170 0.8×	83 0.9×	10	601
Aurélie Cazet France	14	839 1.9×	203 0.7×	140 0.5×	277 1.3×	57 0.6×	23	1.1k
Takuo Suzuki Japan	14	493 1.1×	98 0.3×	299 1.0×	177 0.8×	33 0.3×	23	774
Gowri Rangaswamy Gunassekaran South Korea	13	517 1.1×	161 0.6×	59 0.2×	348 1.6×	198 2.0×	14	880

Countries citing papers authored by Liqiang Pan

Since Specialization

Citations

This map shows the geographic impact of Liqiang Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqiang Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqiang Pan more than expected).

Fields of papers citing papers by Liqiang Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqiang Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqiang Pan. The network helps show where Liqiang Pan may publish in the future.

Co-authorship network of co-authors of Liqiang Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Liqiang Pan. A scholar is included among the top collaborators of Liqiang Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqiang Pan. Liqiang Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Liqiang, et al.. (2025). Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer. Journal for ImmunoTherapy of Cancer. 13(3). e010140–e010140. 6 indexed citations

Sun, Li, Xuefei Bai, Shijie Jin, et al.. (2025). Cathepsin B dependent activatable trigger fluorophore (CAT-Fluor) for in situ functional imaging of antibody-drug conjugates. Biosensors and Bioelectronics. 274. 117184–117184. 3 indexed citations

Jin, Shijie, et al.. (2024). DNA self-assembly-mediated high drug-antibody ratio ADC platform for targeted tumor therapy and imaging. Nano Today. 58. 102459–102459. 2 indexed citations

Zhang, Xing, et al.. (2024). Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides. Angewandte Chemie. 137(3). 1 indexed citations

Zhang, Xing, et al.. (2024). Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides. Angewandte Chemie International Edition. 64(3). e202415272–e202415272. 5 indexed citations

Li, Yiming, Wenbin Zhao, Ying Shen, et al.. (2024). T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy. Biomedicines. 12(4). 776–776. 1 indexed citations

Liang, Xiao, Yanping Sun, Shijie Jin, et al.. (2024). A general pHLA-CD80 scaffold fusion protein to promote efficient antigen-specific T cell-based immunotherapy. SHILAP Revista de lepidopterología. 32(3). 200827–200827.

Wang, Zhe, Xuefei Bai, Yingchun Xu, et al.. (2022). Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance. Nature Communications. 13(1). 4431–4431. 12 indexed citations

Jin, Shijie, Yanping Sun, Liang Xiao, et al.. (2022). Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduction and Targeted Therapy. 7(1). 39–39. 294 indexed citations breakdown →

10.

Yang, Xiaoyue, Yue Wu, Zhiming Ma, et al.. (2021). Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy. Nanomedicine Nanotechnology Biology and Medicine. 37. 102443–102443. 35 indexed citations

11.

Zhao, Linlin, Qingshan Fu, Liqiang Pan, Alessandro Piai, & James J. Chou. (2020). The Diversity and Similarity of Transmembrane Trimerization of TNF Receptors. Frontiers in Cell and Developmental Biology. 8. 569684–569684. 20 indexed citations

12.

Shen, Ying, Xiaoyue Wei, Shijie Jin, et al.. (2020). TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation. Asian Journal of Pharmaceutical Sciences. 15(6). 777–785. 15 indexed citations

13.

Zhang, Ying, Gaoqi Weng, Xiaoyue Yang, et al.. (2019). <p>Identification of an Activating Mutation in the Extracellular Domain of HER2 Conferring Resistance to Pertuzumab</p>. OncoTargets and Therapy. Volume 12. 11597–11608. 16 indexed citations

14.

Pan, Liqiang, Tian‐Min Fu, Wenbin Zhao, et al.. (2019). Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling. Cell. 176(6). 1477–1489.e14. 105 indexed citations

15.

Liu, Wenhui, Wenbin Zhao, Xuefei Bai, et al.. (2019). High antitumor activity of Sortase A-generated anti-CD20 antibody fragment drug conjugates. European Journal of Pharmaceutical Sciences. 134. 81–92. 21 indexed citations

16.

Lai, Jun, Yun Wang, Shanshan Wu, et al.. (2018). Elimination of melanoma by sortase A-generated TCR-like antibody-drug conjugates (TL-ADCs) targeting intracellular melanoma antigen MART-1. Biomaterials. 178. 158–169. 19 indexed citations

17.

Pan, Liqiang, Wenbin Zhao, Jun Lai, et al.. (2015). Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities. Scientific Reports. 5(1). 14872–14872. 9 indexed citations

18.

Pan, Liqiang, Haibin Wang, Zhaohui Li, et al.. (2013). Novel Conjugation of Tumor‐Necrosis‐Factor‐Related Apoptosis‐Inducing Ligand (TRAIL) with Monomethyl Auristatin E for Efficient Antitumor Drug Delivery. Advanced Materials. 25(34). 4718–4722. 26 indexed citations

19.

Liu, Xin, et al.. (2013). The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia. Biomaterials. 34(28). 6893–6905. 82 indexed citations

20.

Pan, Liqiang, Haibin Wang, Jun Lai, et al.. (2013). Site-specific PEGylation of a mutated-cysteine residue and its effect on tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). Biomaterials. 34(36). 9115–9123. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact